fig3

Figure 3. Design of an mRNA vaccine candidate against RSV and SARS-CoV-2^[86]. RSV: Respiratory syncytial virus; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2. SF-LNP: Lipid nanoparticle which delivered mRNAs encoding SARS-CoV-2 Omicron spike (S) and RSV fusion (F) proteins simultaneously;S-LNP: lipid nanoparticle which delivered mRNAs encoding SARS-CoV-2 Omicron spike (S) proteins; F-LNP: lipid nanoparticle which delivered mRNAs encoding RSV fusion (F) proteins.